CompletedNot Applicable

Observational Study of Meloxicam in Any Labeled Indication

13,039 participantsStarted 2001-01

Plain-language summary

Evaluation on the amelioration of symptom intensity of the indication and to evaluate drug tolerability.

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients according to the physicians medical criteria on the labeled indications for Meloxicam Exclusion Criteria: * none

Change in assessment of intensity of pain on a 4-point verbal rating scale

Timeframe: up to 1 year

Assessment of tolerability on a 4-point scale

Timeframe: up to 1 year

NCT IDNCT02182739

SponsorBoehringer Ingelheim

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2001-12